Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Many Firsts Among The Drugs That Launched In 2023

Jan 01 2024

• By Jessica Merrill

diving board — Many innovative new drugs launched in 2023 • Source: Shutterstock

Related Content

Apellis Set For Blockbuster Success With Syfovre, The First Approved Geographic Atrophy Drug

Feb 20 2023

Fewer Drug Launches In 2022, But Standouts Among Them

Jan 03 2023

Vertex/CRISPR Nab First-Ever Gene Editing FDA Nod, Overshadow Bluebird’s Same-Day Win

Dec 09 2023

Lilly’s Zepbound: The Biggest-Selling Drug In The World, Ever?

Nov 15 2023

A Strong Launch For Sarepta’s Elevidys, But Future Hinges On FDA Decision

Nov 02 2023

Panic Not, Say Analysts As Apellis’s Syfovre Launch Is Beset By Retinal Vasculitis Events

Jul 18 2023

Leqembi Treatment Infrastructure: If Medicare Pays For It, They Will Come

Jul 08 2023

Revance's Daxxify Is Approved As Rival To Botox With Longer Efficacy

Sep 08 2022

Related Companies

Eisai Co., Ltd.

Biogen, Inc.

Genetix Biotherapeutics

Vertex Pharmaceuticals Incorporated

CRISPR Therapeutics AG

Revance Therapeutics, Inc.

Pfizer Inc.

GSK plc

Sanofi

AstraZeneca PLC

Apellis Pharmaceuticals, Inc.

Astellas Pharma, Inc.

Iveric Bio, Inc.

Eli Lilly and Company

Sarepta Therapeutics, Inc.

BioMarin Pharmaceutical Inc.

Additional Topics

Innovation Business Strategies Approvals BioPharmaceutical

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window